Kurt N Bausback, MD
Interventional Cardiology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 3 carriers
- Offices
- 14
Offices
14 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bausback’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G57335 · Current
Licensed to practise in California · since 1986 · expires 2028-02-29 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$350,068
Medicare paid this office $350,068 for 1,491 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 792 | $122,348 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $46,708 | $190 |
| Long return visit (40+ min) | 220 | $46,354 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $25,619 | $106 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 85 | $19,762 | $232 |
See all 24 services
| Return visit (30+ min) | 792 | $122,348 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $46,708 | $190 |
| Long return visit (40+ min) | 220 | $46,354 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $25,619 | $106 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 85 | $19,762 | $232 |
| New patient visit (45+ min) | 82 | $11,680 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,928 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $9,179 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 440 | $6,735 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 75 | $5,139 | $65 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $4,845 | $53 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 55 | $3,574 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 56 | $3,236 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 130 | $3,084 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 86 | $2,209 | $26 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,097 | $161 |
| Heart rhythm recording of continous external ekg over 8-15 days | 130 | $1,800 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 60 | $1,597 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $1,382 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 181 | $1,339 | $7 |
| Programming of dual lead pacemaker system | 35 | $1,130 | $31 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 20 | $741 | $37 |
| Short return visit | 12 | $506 | $39 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $179 | $11 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
1,491 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 23% · Women 49% · Also on Medicaid 6% · Health risk score 1.29. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 39% · Atrial fibrillation 34% · Diabetes 30% · Chronic kidney disease 27% · Heart failure 21% · Cancer 19% · Depression 18% · Stroke 14% · COPD 12% · Dementia 10%.
The office billed $1,431,710, Medicare allowed $478,147 and paid $350,068; for 4,220 services of 52 kinds; $377 of it was for drugs given in the office and $349,691 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,491 | 4,220 | 79 | 1.29 | $1,431,710 | $350,068 |
| 2023 | 1,477 | 4,309 | 78 | 1.25 | $1,456,634 | $379,406 |
| 2022 | 1,432 | 4,399 | 79 | 1.22 | $1,437,532 | $393,885 |
| 2021 | 1,417 | 4,263 | 78 | 1.28 | $1,348,281 | $386,320 |
| 2020 | 1,284 | 4,191 | 78 | 1.38 | $1,248,698 | $356,461 |
| 2019 | 1,297 | 4,144 | 79 | 1.49 | $1,319,874 | $352,811 |
| 2018 | 1,232 | 4,357 | 78 | 1.47 | $1,305,895 | $349,022 |
| 2017 | 1,218 | 4,622 | 78 | 1.43 | $1,383,667 | $377,644 |
| 2016 | 1,115 | 4,516 | 78 | 1.49 | $1,234,070 | $375,190 |
| 2015 | 1,149 | 6,593 | 78 | 1.42 | $1,133,408 | $447,353 |
| 2014 | 993 | 6,637 | 78 | 1.32 | $1,167,166 | $462,542 |
| 2013 | 916 | 5,481 | 78 | 1.32 | $967,514 | $367,173 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 31 services
| Long return visit (40+ min) | 392 | $90,156 | $161 |
| Return visit (30+ min) | 588 | $85,536 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $49,497 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $32,631 | $109 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 81 | $19,466 | $235 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $14,754 | $157 |
| New patient visit (45+ min) | 74 | $10,341 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $8,773 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 452 | $8,164 | $14 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,488 | $422 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $4,921 | $447 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $4,126 | $70 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 11 | $3,694 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $3,567 | $162 |
| Short return visit | 48 | $3,157 | $54 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 108 | $2,701 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 45 | $2,666 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 47 | $2,618 | $22 |
| Injection, regadenoson, 0.1 mg | 17 | $2,455 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 80 | $2,150 | $26 |
| Programming of dual lead pacemaker system | 43 | $1,814 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 207 | $1,517 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 107 | $1,514 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,489 | $21 |
| External shock to heart to regulate heart beat | 13 | $1,268 | $98 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 23 | $625 | $27 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 14 | $427 | $15 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $303 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $286 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $189 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $130 | $11 |
2022: 26 services
| Return visit (30+ min) | 702 | $109,916 | $109 |
| Long return visit (40+ min) | 358 | $85,221 | $161 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 209 | $44,093 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 154 | $34,752 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $20,159 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 86 | $19,748 | $230 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $11,460 | $64 |
| New patient visit (45+ min) | 79 | $11,194 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 423 | $6,879 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 79 | $3,738 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 70 | $3,526 | $24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,284 | $182 |
| New patient visit (60+ min) | 11 | $2,314 | $210 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 16 | $2,290 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 86 | $2,285 | $27 |
| Short return visit | 33 | $2,279 | $53 |
| Programming of dual lead pacemaker system | 48 | $2,168 | $40 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $2,155 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 78 | $1,906 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,899 | $68 |
| External shock to heart to regulate heart beat | 12 | $1,224 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 166 | $1,209 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 77 | $1,192 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $334 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $281 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $188 | $13 |
2021: 27 services
| Return visit (30+ min) | 700 | $119,759 | $111 |
| Long return visit (40+ min) | 302 | $66,624 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | $49,337 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 137 | $27,040 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 80 | $19,709 | $243 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $15,245 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $10,108 | $66 |
| New patient visit (45+ min) | 66 | $9,444 | $143 |
| Transitional care management services for problem of high complexity | 23 | $6,374 | $277 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,356 | $578 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 368 | $6,208 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 91 | $5,174 | $25 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $4,429 | $170 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 80 | $4,411 | $25 |
| Short return visit | 56 | $3,354 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 79 | $2,217 | $28 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 22 | $2,141 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 85 | $2,131 | $24 |
| New patient visit (30+ min) | 16 | $1,757 | $110 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 24 | $1,739 | $72 |
| Programming of dual lead pacemaker system | 48 | $1,624 | $31 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 18 | $1,594 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 85 | $1,411 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 170 | $1,393 | $7 |
| Short return visit (20+ min) | 16 | $1,136 | $67 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $781 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $412 | $11 |
2020: 27 services
| Return visit (30+ min) | 718 | $110,401 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $48,549 | $213 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 165 | $41,264 | $96 |
| Long return visit (40+ min) | 111 | $22,100 | $142 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 89 | $21,250 | $236 |
| Telephone medical discussion with physician, 21-30 minutes | 136 | $15,088 | $106 |
| New patient visit (45+ min) | 78 | $11,829 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $11,557 | $186 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | $10,470 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 281 | $5,946 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 79 | $4,760 | $26 |
| Transitional care management services for problem of high complexity | 15 | $3,985 | $266 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 67 | $3,983 | $26 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $3,849 | $203 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 21 | $3,641 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 89 | $2,504 | $28 |
| External ekg recording for more than 48 hours up to 21 days | 81 | $2,330 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 81 | $2,054 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $1,691 | $22 |
| Programming of dual lead pacemaker system | 41 | $1,632 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 23 | $1,489 | $65 |
| New patient visit (15+ min) | 17 | $1,151 | $68 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,016 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 99 | $872 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $831 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $341 | $11 |
| Heart muscle strain imaging | 11 | $133 | $11 |
2019: 25 services
| Return visit (30+ min) | 750 | $114,890 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 200 | $52,514 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $40,872 | $198 |
| Long return visit (40+ min) | 164 | $35,336 | $128 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 103 | $24,532 | $236 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $13,347 | $65 |
| New patient visit (45+ min) | 61 | $8,323 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,978 | $184 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $4,592 | $26 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,197 | $210 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 205 | $4,125 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 59 | $3,597 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 103 | $2,820 | $27 |
| New patient visit (60+ min) | 15 | $2,789 | $186 |
| Programming of dual lead pacemaker system | 50 | $2,210 | $33 |
| New patient visit (30+ min) | 19 | $1,974 | $104 |
| External ekg recording for more than 48 hours up to 21 days | 62 | $1,775 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 62 | $1,571 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,502 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,288 | $7 |
| New patient visit (15+ min) | 12 | $775 | $65 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 22 | $724 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $633 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $442 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $334 | $11 |
2018: 23 services
| Return visit (30+ min) | 769 | $134,665 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 185 | $48,027 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 191 | $40,578 | $199 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 111 | $25,136 | $226 |
| Long return visit (40+ min) | 91 | $14,328 | $136 |
| New patient visit (45+ min) | 86 | $11,605 | $135 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $10,781 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,530 | $178 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 274 | $5,869 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 76 | $5,025 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | $3,602 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 111 | $3,002 | $27 |
| Short return visit (20+ min) | 40 | $2,803 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $2,419 | $47 |
| Programming of dual lead pacemaker system | 58 | $2,334 | $29 |
| External ekg recording for more than 48 hours up to 21 days | 82 | $2,185 | $25 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,057 | $171 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 82 | $1,935 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,337 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 140 | $1,131 | $8 |
| New patient visit (30+ min) | 12 | $1,109 | $92 |
| Short return visit | 17 | $767 | $43 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $520 | $19 |
2017: 27 services
| Return visit (30+ min) | 768 | $150,653 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $47,567 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $44,424 | $216 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 153 | $40,779 | $261 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $16,871 | $174 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $10,928 | $55 |
| New patient visit (45+ min) | 55 | $7,414 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 295 | $5,934 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 151 | $4,010 | $26 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,480 | $268 |
| Programming of dual lead pacemaker system | 52 | $3,383 | $31 |
| Long return visit (40+ min) | 23 | $2,974 | $124 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 47 | $2,828 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 92 | $2,810 | $27 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,494 | $192 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 92 | $2,451 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $2,085 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $2,016 | $28 |
| Short return visit (20+ min) | 35 | $1,802 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $1,603 | $62 |
| External shock to heart to regulate heart beat | 11 | $1,075 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 133 | $1,052 | $7 |
| Programming of dual lead implantable defibrillator system | 13 | $1,022 | $46 |
| Initial hospital observation care per day, typically 30 minutes | 11 | $948 | $86 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $661 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $428 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $287 | $13 |
2016: 31 services
| Return visit (30+ min) | 727 | $135,430 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $45,291 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $41,492 | $223 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 97 | $25,366 | $256 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 41 | $20,082 | $490 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,612 | $178 |
| Short return visit (20+ min) | 130 | $9,034 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $8,914 | $57 |
| New patient visit (45+ min) | 61 | $8,755 | $144 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 41 | $6,393 | $95 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,205 | $477 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 276 | $6,152 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 63 | $4,375 | $67 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 34 | $3,465 | $26 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $2,815 | $176 |
| Programming of dual lead pacemaker system | 43 | $2,796 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 96 | $2,618 | $27 |
| Long return visit (40+ min) | 17 | $2,422 | $135 |
| Programming of dual lead implantable defibrillator system | 21 | $2,208 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 72 | $1,610 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,549 | $74 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,452 | $58 |
| Blood test, clotting time | 84 | $1,239 | $5 |
| External shock to heart to regulate heart beat | 11 | $1,224 | $111 |
| Initial hospital observation care per day, typically 30 minutes | 12 | $1,061 | $88 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 23 | $984 | $27 |
| Short return visit | 26 | $790 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $767 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $603 | $55 |
| External ekg recording for more than 48 hours up to 21 days | 17 | $478 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $409 | $24 |
2015: 35 services
| Return visit (30+ min) | 751 | $138,808 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 104 | $52,302 | $493 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 210 | $49,180 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $31,286 | $223 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 101 | $27,217 | $269 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 104 | $18,179 | $131 |
| New patient visit (45+ min) | 82 | $11,592 | $141 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 149 | $10,247 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 132 | $9,332 | $65 |
| Ultrasound of both sides of head and neck blood flow | 40 | $8,007 | $200 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,659 | $383 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $7,090 | $55 |
| Blood test, clotting time | 134 | $6,807 | $5 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 87 | $6,053 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | $5,352 | $16 |
| Programming of dual lead pacemaker system | 46 | $4,384 | $49 |
| Injection, regadenoson, 0.1 mg | 27 | $4,225 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,115 | $179 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,080 | $170 |
| Short return visit | 104 | $3,920 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 42 | $3,647 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 103 | $2,751 | $27 |
| Programming of dual lead implantable defibrillator system | 14 | $2,284 | $67 |
| New patient visit (30+ min) | 29 | $2,264 | $78 |
| External shock to heart to regulate heart beat | 14 | $1,739 | $109 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,140 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 111 | $999 | $8 |
| Programming of single lead pacemaker system | 15 | $972 | $39 |
| Initial hospital observation care per day, typically 30 minutes | 11 | $970 | $81 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 15 | $660 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $638 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $238 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $155 | $13 |
| Injection, aminophyllin, up to 250 mg | 27 | $110 | None |
| Infusion, normal saline solution, 250 cc | 28 | $9 | None |
2014: 34 services
| Return visit (30+ min) | 723 | $131,728 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 127 | $63,123 | $493 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 204 | $49,017 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $36,610 | $221 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 86 | $24,246 | $276 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 127 | $19,794 | $131 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 156 | $11,080 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 165 | $10,792 | $18 |
| New patient visit (45+ min) | 63 | $9,077 | $144 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 129 | $7,835 | $56 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 106 | $7,269 | $17 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,975 | $465 |
| Blood test, clotting time | 130 | $6,717 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 227 | $6,114 | $15 |
| Ultrasound of both sides of head and neck blood flow | 29 | $5,681 | $196 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $5,067 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,989 | $178 |
| Programming of dual lead pacemaker system | 51 | $4,844 | $50 |
| Injection, regadenoson, 0.1 mg | 29 | $4,815 | None |
| Short return visit | 123 | $4,681 | $38 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,507 | $195 |
| External shock to heart to regulate heart beat | 24 | $3,093 | $110 |
| Initial hospital observation care per day, typically 70 minutes | 16 | $2,864 | $159 |
| New patient visit (30+ min) | 32 | $2,738 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,678 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,431 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 85 | $2,288 | $26 |
| Programming of dual lead implantable defibrillator system | 11 | $2,143 | $71 |
| Programming of single lead pacemaker system | 13 | $988 | $41 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $788 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $218 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $143 | $12 |
| Injection, aminophyllin, up to 250 mg | 29 | $59 | None |
| Infusion, normal saline solution, 250 cc | 30 | $8 | None |
2013: 36 services
| Return visit (30+ min) | 593 | $107,565 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 101 | $54,541 | $510 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 154 | $36,267 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 115 | $21,024 | $178 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $15,515 | $232 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 101 | $15,502 | $132 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 125 | $9,366 | $67 |
| New patient visit (45+ min) | 69 | $9,344 | $135 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 160 | $8,627 | $18 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $7,064 | $416 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 89 | $6,532 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 105 | $6,283 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 236 | $5,892 | $17 |
| Ultrasound of both sides of head and neck blood flow | 31 | $5,716 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,475 | $166 |
| Blood test, clotting time | 144 | $5,111 | $5 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,674 | $195 |
| Injection, regadenoson, 0.1 mg | 24 | $4,212 | None |
| Programming of dual lead pacemaker system | 45 | $4,032 | $50 |
| Short return visit | 98 | $3,817 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 37 | $3,037 | $78 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,478 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,874 | $62 |
| Programming of dual lead implantable defibrillator system | 15 | $1,784 | $66 |
| Hospital observation care on day of discharge | 25 | $1,452 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 67 | $1,356 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $1,009 | $50 |
| Programming of single lead pacemaker system | 11 | $889 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $657 | $25 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $467 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $413 | $7 |
| Liver enzyme (sgot), level | 17 | $107 | $6 |
| Liver enzyme (sgpt), level | 17 | $107 | $6 |
| Blood glucose (sugar) test performed by hand-held instrument | 18 | $83 | $3 |
| Injection, aminophyllin, up to 250 mg | 24 | $19 | None |
| Infusion, normal saline solution, 250 cc | 24 | $6 | None |
Medicaid work
$1,079 in 2024
Medicaid paid $1,079 for 102 billed services this clinician did in 2024, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $737 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 88 | $341 |
| 2024 | 102 | 2 | 33 | $1,079 |
| 2023 | 63 | 1 | 24 | $234 |
| 2022 | 47 | 1 | 18 | $184 |
| 2021 | 32 | 1 | 17 | $109 |
| 2020 | 17 | 1 | 13 | $35 |
| 2019 | 13 | 1 | 13 | $12 |
| 2018 | 41 | 1 | 14 | $182 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 63 | $234 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 47 | $184 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 32 | $109 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 17 | $35 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $12 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 41 | $182 |
Drugs they prescribed that Part D paid
$909,438
Pharmacies billed $909,438 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,696) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
4,013 generic and 683 brand-name prescriptions · $909,438 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 310 | $460,411 | $1,485 |
| Repatha Sureclick | 115 | $117,939 | $1,026 |
| Xarelto | 50 | $72,632 | $1,453 |
| Entresto | 48 | $58,768 | $1,224 |
| Jardiance | 32 | $44,682 | $1,396 |
See all 55 drugs
| Eliquis | 310 | $460,411 | $1,485 |
| Repatha Sureclick | 115 | $117,939 | $1,026 |
| Xarelto | 50 | $72,632 | $1,453 |
| Entresto | 48 | $58,768 | $1,224 |
| Jardiance | 32 | $44,682 | $1,396 |
| Praluent | 27 | $36,065 | $1,336 |
| Brilinta | 23 | $17,968 | $781 |
| Diltiazem 24hr Er (Cd) | 203 | $7,756 | $38 |
| Metoprolol | 339 | $6,215 | $18 |
| Losartan | 374 | $6,190 | $17 |
| Flecainide Acetate | 94 | $6,016 | $64 |
| Rosuvastatin | 320 | $5,614 | $18 |
| Atorvastatin | 420 | $5,057 | $12 |
| Ezetimibe | 108 | $3,908 | $36 |
| Amlodipine Besylate | 369 | $3,846 | $10 |
| Potassium Chloride | 79 | $2,881 | $36 |
| Metoprolol | 159 | $2,212 | $14 |
| Propafenone | 20 | $1,585 | $79 |
| Sotalol Af | 49 | $1,526 | $31 |
| Lisinopril | 90 | $1,319 | $15 |
| Diltiazem 24hr Er | 25 | $1,280 | $51 |
| Diltiazem 24hr Er (Xr) | 15 | $1,164 | $78 |
| Hydrochlorothiazide | 138 | $1,110 | $8 |
| Sotalol | 44 | $1,095 | $25 |
| Digoxin | 35 | $1,092 | $31 |
| Simvastatin | 93 | $1,090 | $12 |
| Nebivolol | 11 | $1,080 | $98 |
| Hydralazine | 41 | $1,016 | $25 |
| Clopidogrel | 75 | $1,005 | $13 |
| Isosorbide Mononitrate Er | 37 | $985 | $27 |
| Valsartan | 27 | $969 | $36 |
| Carvedilol | 95 | $951 | $10 |
| Amiodarone | 31 | $874 | $28 |
| Pravastatin | 35 | $784 | $22 |
| Olmesartan Medoxomil | 18 | $736 | $41 |
| Atenolol | 81 | $720 | $9 |
| Furosemide | 82 | $708 | $9 |
| Triamterene-Hydrochlorothiazid | 46 | $691 | $15 |
| Losartan-Hydrochlorothiazide | 29 | $675 | $23 |
| Verapamil Er | 27 | $636 | $24 |
| Metolazone | 14 | $564 | $40 |
| Nitroglycerin | 43 | $481 | $11 |
| Fenofibrate | 12 | $418 | $35 |
| Spironolactone | 16 | $337 | $21 |
| Enalapril Maleate | 21 | $334 | $16 |
| Cartia Xt | 14 | $327 | $23 |
| Warfarin | 28 | $304 | $11 |
| Clonidine | 34 | $291 | $9 |
| Chlorthalidone | 13 | $248 | $19 |
| Benazepril | 20 | $190 | $9 |
| Propranolol | 21 | $185 | $9 |
| Lisinopril-Hydrochlorothiazide | 14 | $104 | $7 |
| Ramipril | 19 | $88 | $5 |
| Doxazosin Mesylate | 11 | $67 | $6 |
| Amoxicillin | 13 | $63 | $5 |
Year by year
| 2024 | 4,696 | 624 | 0% (0) | 15% | $909,438 |
| 2023 | 4,724 | 610 | 0% (0) | 14% | $856,752 |
| 2022 | 4,630 | 601 | 0% (0) | 12% | $731,891 |
| 2021 | 4,169 | 580 | 0% (0) | None | $599,859 |
| 2020 | 4,155 | 532 | 0% (0) | 15% | $552,193 |
| 2019 | 4,175 | 528 | 0% (0) | 15% | $539,372 |
| 2018 | 4,286 | 534 | 0% (0) | 14% | $453,633 |
| 2017 | 4,235 | 529 | 0% (0) | None | $431,314 |
| 2016 | 4,686 | 521 | 0% (0) | 18% | $395,645 |
| 2015 | 4,465 | 505 | 0% (0) | None | $319,544 |
| 2014 | 4,012 | 462 | None | 22% | $274,395 |
| 2013 | 3,179 | 359 | None | 22% | $206,702 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Eliquis | 319 | $452,135 | $1,417 |
| Xarelto | 53 | $77,802 | $1,468 |
| Repatha Sureclick | 71 | $61,899 | $872 |
| Entresto | 45 | $51,638 | $1,148 |
| Praluent | 48 | $50,950 | $1,061 |
| Brilinta | 19 | $11,983 | $631 |
| Diltiazem 24hr Er (Cd) | 210 | $9,427 | $45 |
| Losartan | 392 | $6,998 | $18 |
| Metoprolol | 342 | $6,948 | $20 |
| Rosuvastatin | 262 | $6,122 | $23 |
| Flecainide Acetate | 89 | $6,085 | $68 |
| Ezetimibe | 113 | $5,158 | $46 |
| Atorvastatin | 367 | $4,531 | $12 |
| Sotalol Af | 54 | $3,303 | $61 |
| Amlodipine Besylate | 359 | $2,796 | $8 |
| Potassium Chloride | 88 | $2,767 | $31 |
| Propafenone | 21 | $2,522 | $120 |
| Nebivolol | 13 | $2,482 | $191 |
| Sotalol | 53 | $1,809 | $34 |
| Clopidogrel | 94 | $1,736 | $18 |
| Valsartan | 28 | $1,702 | $61 |
| Isosorbide Mononitrate Er | 42 | $1,622 | $39 |
| Metoprolol | 168 | $1,478 | $9 |
| Diltiazem 24hr Er | 25 | $1,389 | $56 |
| Lisinopril | 106 | $1,276 | $12 |
| Simvastatin | 112 | $1,162 | $10 |
| Carvedilol | 98 | $1,071 | $11 |
| Digoxin | 47 | $1,067 | $23 |
| Pravastatin | 40 | $1,048 | $26 |
| Hydrochlorothiazide | 154 | $1,041 | $7 |
| Amiodarone | 17 | $976 | $57 |
| Atenolol | 73 | $974 | $13 |
| Diltiazem 24hr Er (Xr) | 14 | $926 | $66 |
| Hydralazine | 52 | $919 | $18 |
| Valsartan-Hydrochlorothiazide | 18 | $817 | $45 |
| Losartan-Hydrochlorothiazide | 35 | $791 | $23 |
| Verapamil Er | 25 | $777 | $31 |
| Furosemide | 93 | $653 | $7 |
| Nitroglycerin | 38 | $599 | $16 |
| Olmesartan Medoxomil | 20 | $593 | $30 |
| Enalapril Maleate | 19 | $541 | $28 |
| Benazepril | 24 | $534 | $22 |
| Warfarin | 39 | $521 | $13 |
| Diltiazem | 14 | $504 | $36 |
| Doxazosin Mesylate | 15 | $502 | $33 |
| Clonidine | 35 | $494 | $14 |
| Triamterene-Hydrochlorothiazid | 34 | $443 | $13 |
| Torsemide | 21 | $346 | $16 |
| Bumetanide | 13 | $336 | $26 |
| Chlorthalidone | 16 | $295 | $18 |
| Ramipril | 21 | $261 | $12 |
| Propranolol | 15 | $250 | $17 |
| Spironolactone | 24 | $225 | $9 |
2022: 55 drugs
| Eliquis | 316 | $408,455 | $1,293 |
| Repatha Sureclick | 52 | $49,867 | $959 |
| Xarelto | 34 | $47,302 | $1,391 |
| Entresto | 30 | $43,890 | $1,463 |
| Praluent | 24 | $30,572 | $1,274 |
| Brilinta | 14 | $15,802 | $1,129 |
| Rosuvastatin | 255 | $11,431 | $45 |
| Diltiazem 24hr Er (Cd) | 232 | $11,295 | $49 |
| Metoprolol | 332 | $8,155 | $25 |
| Ezetimibe | 99 | $7,722 | $78 |
| Losartan | 375 | $5,964 | $16 |
| Flecainide Acetate | 86 | $5,726 | $67 |
| Atorvastatin | 382 | $4,678 | $12 |
| Propafenone | 28 | $3,208 | $115 |
| Amlodipine Besylate | 310 | $2,864 | $9 |
| Potassium Chloride | 95 | $2,810 | $30 |
| Sotalol | 93 | $2,081 | $22 |
| Sotalol Af | 31 | $2,026 | $65 |
| Metolazone | 26 | $1,805 | $69 |
| Digoxin | 51 | $1,742 | $34 |
| Isosorbide Mononitrate Er | 51 | $1,737 | $34 |
| Valsartan | 30 | $1,527 | $51 |
| Clopidogrel | 87 | $1,348 | $15 |
| Hydralazine | 54 | $1,348 | $25 |
| Carvedilol | 109 | $1,254 | $12 |
| Metoprolol | 137 | $1,212 | $9 |
| Simvastatin | 113 | $1,159 | $10 |
| Lisinopril | 106 | $1,104 | $10 |
| Pravastatin | 38 | $1,102 | $29 |
| Amiodarone | 22 | $1,086 | $49 |
| Warfarin | 56 | $1,053 | $19 |
| Losartan-Hydrochlorothiazide | 39 | $990 | $25 |
| Fenofibrate | 20 | $983 | $49 |
| Hydrochlorothiazide | 128 | $895 | $7 |
| Atenolol | 79 | $819 | $10 |
| Valsartan-Hydrochlorothiazide | 19 | $806 | $42 |
| Bumetanide | 12 | $804 | $67 |
| Diltiazem 24hr Er | 19 | $803 | $42 |
| Nitroglycerin | 45 | $734 | $16 |
| Furosemide | 97 | $609 | $6 |
| Clonidine | 58 | $586 | $10 |
| Olmesartan Medoxomil | 19 | $566 | $30 |
| Verapamil Er | 15 | $530 | $35 |
| Diltiazem | 12 | $509 | $42 |
| Triamterene-Hydrochlorothiazid | 39 | $445 | $11 |
| Enalapril Maleate | 23 | $425 | $18 |
| Diltiazem 24hr Er (Xr) | 11 | $388 | $35 |
| Benazepril | 22 | $344 | $16 |
| Pantoprazole | 14 | $307 | $22 |
| Spironolactone | 14 | $279 | $20 |
| Doxazosin Mesylate | 16 | $267 | $17 |
| Ramipril | 25 | $191 | $8 |
| Propranolol | 15 | $189 | $13 |
| Klor-Con 10 | 13 | $172 | $13 |
| Torsemide | 11 | $131 | $12 |
2021: 55 drugs
| Eliquis | 280 | $310,612 | $1,109 |
| Repatha Sureclick | 53 | $41,475 | $783 |
| Xarelto | 27 | $35,705 | $1,322 |
| Praluent | 40 | $31,377 | $784 |
| Entresto | 23 | $30,159 | $1,311 |
| Brilinta | 13 | $11,451 | $881 |
| Rosuvastatin | 200 | $10,711 | $54 |
| Diltiazem 24hr Er (Cd) | 188 | $9,036 | $48 |
| Losartan | 377 | $7,277 | $19 |
| Metoprolol | 284 | $6,872 | $24 |
| Flecainide Acetate | 68 | $6,069 | $89 |
| Ezetimibe | 78 | $5,544 | $71 |
| Potassium Chloride | 93 | $5,210 | $56 |
| Atorvastatin | 321 | $4,542 | $14 |
| Propafenone | 24 | $2,418 | $101 |
| Amlodipine Besylate | 272 | $2,187 | $8 |
| Sotalol | 93 | $2,047 | $22 |
| Metolazone | 24 | $1,845 | $77 |
| Isosorbide Mononitrate Er | 49 | $1,695 | $35 |
| Carvedilol | 96 | $1,626 | $17 |
| Warfarin | 62 | $1,481 | $24 |
| Metoprolol | 148 | $1,466 | $10 |
| Sotalol Af | 38 | $1,376 | $36 |
| Amiodarone | 38 | $1,370 | $36 |
| Lisinopril | 107 | $1,288 | $12 |
| Digoxin | 34 | $1,233 | $36 |
| Valsartan | 19 | $1,166 | $61 |
| Simvastatin | 106 | $1,067 | $10 |
| Enalapril Maleate | 22 | $1,028 | $47 |
| Clopidogrel | 53 | $1,023 | $19 |
| Losartan-Hydrochlorothiazide | 45 | $974 | $22 |
| Fenofibrate | 18 | $971 | $54 |
| Verapamil Er | 20 | $969 | $48 |
| Atenolol | 65 | $858 | $13 |
| Hydralazine | 44 | $841 | $19 |
| Diltiazem 24hr Er | 16 | $836 | $52 |
| Furosemide | 88 | $813 | $9 |
| Doxazosin Mesylate | 22 | $805 | $37 |
| Hydrochlorothiazide | 110 | $792 | $7 |
| Bumetanide | 15 | $762 | $51 |
| Cartia Xt | 16 | $738 | $46 |
| Valsartan-Hydrochlorothiazide | 12 | $718 | $60 |
| Pravastatin | 28 | $705 | $25 |
| Dilt-Xr | 11 | $662 | $60 |
| Nitroglycerin | 32 | $605 | $19 |
| Diltiazem | 14 | $590 | $42 |
| Triamterene-Hydrochlorothiazid | 32 | $511 | $16 |
| Spironolactone | 24 | $450 | $19 |
| Pantoprazole | 13 | $343 | $26 |
| Benazepril | 18 | $332 | $18 |
| Clonidine | 41 | $315 | $8 |
| Torsemide | 13 | $251 | $19 |
| Ramipril | 19 | $218 | $11 |
| Propranolol | 13 | $141 | $11 |
| Klor-Con 10 | 11 | $140 | $13 |
2020: 56 drugs
| Eliquis | 292 | $278,264 | $953 |
| Xarelto | 42 | $42,574 | $1,014 |
| Repatha Sureclick | 38 | $32,521 | $856 |
| Praluent | 31 | $20,455 | $660 |
| Entresto | 16 | $14,922 | $933 |
| Brilinta | 14 | $13,197 | $943 |
| Rosuvastatin | 180 | $11,299 | $63 |
| Diltiazem 24hr Er (Cd) | 156 | $10,316 | $66 |
| Metoprolol | 273 | $8,978 | $33 |
| Ezetimibe | 90 | $7,044 | $78 |
| Losartan | 358 | $6,486 | $18 |
| Atorvastatin | 317 | $5,994 | $19 |
| Potassium Chloride | 112 | $5,732 | $51 |
| Flecainide Acetate | 64 | $5,365 | $84 |
| Propafenone | 23 | $2,796 | $122 |
| Metolazone | 21 | $2,584 | $123 |
| Losartan-Hydrochlorothiazide | 39 | $2,547 | $65 |
| Bumetanide | 40 | $2,506 | $63 |
| Sotalol Af | 45 | $2,189 | $49 |
| Warfarin | 83 | $2,164 | $26 |
| Sotalol | 85 | $2,086 | $25 |
| Amlodipine Besylate | 257 | $1,691 | $7 |
| Metoprolol | 162 | $1,659 | $10 |
| Fenofibrate | 21 | $1,595 | $76 |
| Cartia Xt | 32 | $1,469 | $46 |
| Hydralazine | 63 | $1,452 | $23 |
| Carvedilol | 100 | $1,448 | $14 |
| Valsartan | 17 | $1,414 | $83 |
| Lisinopril | 97 | $1,216 | $13 |
| Simvastatin | 112 | $1,134 | $10 |
| Pravastatin | 32 | $1,116 | $35 |
| Digoxin | 25 | $1,110 | $44 |
| Verapamil Er | 26 | $1,041 | $40 |
| Doxazosin Mesylate | 23 | $1,006 | $44 |
| Diltiazem | 12 | $996 | $83 |
| Olmesartan Medoxomil | 15 | $959 | $64 |
| Amiodarone | 19 | $911 | $48 |
| Clopidogrel | 45 | $908 | $20 |
| Enalapril Maleate | 20 | $894 | $45 |
| Isosorbide Mononitrate Er | 31 | $890 | $29 |
| Furosemide | 104 | $840 | $8 |
| Dilt-Xr | 16 | $821 | $51 |
| Diltiazem 24hr Er | 12 | $774 | $64 |
| Atenolol | 63 | $759 | $12 |
| Valsartan-Hydrochlorothiazide | 13 | $695 | $53 |
| Triamterene-Hydrochlorothiazid | 40 | $632 | $16 |
| Hydrochlorothiazide | 103 | $611 | $6 |
| Spironolactone | 27 | $585 | $22 |
| Pantoprazole | 14 | $408 | $29 |
| Benazepril | 20 | $365 | $18 |
| Clonidine | 45 | $363 | $8 |
| Nitroglycerin | 26 | $348 | $13 |
| Torsemide | 11 | $264 | $24 |
| Klor-Con 10 | 16 | $251 | $16 |
| Propranolol | 16 | $155 | $10 |
| Ramipril | 11 | $110 | $10 |
2019: 56 drugs
| Eliquis | 287 | $238,888 | $832 |
| Xarelto | 52 | $54,660 | $1,051 |
| Repatha Sureclick | 26 | $28,099 | $1,081 |
| Entresto | 22 | $21,930 | $997 |
| Praluent | 23 | $18,909 | $822 |
| Brilinta | 34 | $14,882 | $438 |
| Rosuvastatin | 179 | $11,362 | $63 |
| Metoprolol | 265 | $10,410 | $39 |
| Diltiazem 24hr Er (Cd) | 138 | $9,711 | $70 |
| Atorvastatin | 318 | $6,316 | $20 |
| Potassium Chloride | 106 | $5,991 | $57 |
| Ezetimibe | 92 | $5,741 | $62 |
| Flecainide Acetate | 59 | $5,682 | $96 |
| Losartan | 308 | $5,376 | $17 |
| Cartia Xt | 82 | $3,810 | $46 |
| Bumetanide | 45 | $3,458 | $77 |
| Coumadin | 13 | $3,371 | $259 |
| Sotalol | 89 | $3,233 | $36 |
| Warfarin | 114 | $3,002 | $26 |
| Metolazone | 24 | $2,449 | $102 |
| Propafenone | 20 | $2,156 | $108 |
| Amlodipine Besylate | 222 | $2,086 | $9 |
| Carvedilol | 109 | $1,861 | $17 |
| Pravastatin | 43 | $1,619 | $38 |
| Metoprolol | 158 | $1,617 | $10 |
| Fenofibrate | 19 | $1,581 | $83 |
| Sotalol Af | 44 | $1,559 | $35 |
| Simvastatin | 115 | $1,446 | $13 |
| Isosorbide Mononitrate Er | 32 | $1,179 | $37 |
| Digoxin | 17 | $1,104 | $65 |
| Valsartan | 20 | $1,093 | $55 |
| Lisinopril | 87 | $1,090 | $13 |
| Clopidogrel | 55 | $1,069 | $19 |
| Doxazosin Mesylate | 19 | $947 | $50 |
| Verapamil Er | 22 | $909 | $41 |
| Enalapril Maleate | 22 | $880 | $40 |
| Losartan-Hydrochlorothiazide | 41 | $828 | $20 |
| Hydralazine | 39 | $791 | $20 |
| Furosemide | 97 | $721 | $7 |
| Hydrochlorothiazide | 98 | $670 | $7 |
| Atenolol | 63 | $666 | $11 |
| Triamterene-Hydrochlorothiazid | 50 | $656 | $13 |
| Valsartan-Hydrochlorothiazide | 18 | $629 | $35 |
| Digox | 12 | $607 | $51 |
| Amiodarone | 24 | $604 | $25 |
| Spironolactone | 28 | $590 | $21 |
| Torsemide | 13 | $535 | $41 |
| Dilt-Xr | 12 | $452 | $38 |
| Olmesartan Medoxomil | 12 | $439 | $37 |
| Clonidine | 47 | $361 | $8 |
| Benazepril | 19 | $353 | $19 |
| Quinapril | 15 | $336 | $22 |
| Pantoprazole | 15 | $329 | $22 |
| Propranolol | 25 | $302 | $12 |
| Nitroglycerin | 17 | $238 | $14 |
| Ramipril | 12 | $152 | $13 |
2018: 61 drugs
| Eliquis | 242 | $174,106 | $719 |
| Xarelto | 42 | $37,435 | $891 |
| Repatha Sureclick | 13 | $18,967 | $1,459 |
| Pradaxa | 17 | $15,800 | $929 |
| Entresto | 22 | $13,550 | $616 |
| Ezetimibe | 75 | $11,766 | $157 |
| Metoprolol | 310 | $11,453 | $37 |
| Ranexa | 20 | $11,375 | $569 |
| Rosuvastatin | 167 | $9,269 | $56 |
| Flecainide Acetate | 88 | $8,699 | $99 |
| Brilinta | 13 | $8,453 | $650 |
| Atorvastatin | 320 | $7,066 | $22 |
| Cartia Xt | 130 | $5,338 | $41 |
| Prasugrel | 20 | $5,248 | $262 |
| Potassium Chloride | 117 | $5,216 | $45 |
| Warfarin | 184 | $5,082 | $28 |
| Losartan | 306 | $4,417 | $14 |
| Metolazone | 48 | $3,974 | $83 |
| Diltiazem 24hr Er (Cd) | 88 | $3,891 | $44 |
| Coumadin | 13 | $2,988 | $230 |
| Sotalol | 100 | $2,859 | $29 |
| Ezetimibe-Simvastatin | 11 | $2,824 | $257 |
| Sotalol Af | 37 | $2,024 | $55 |
| Digox | 24 | $1,996 | $83 |
| Digoxin | 34 | $1,926 | $57 |
| Metoprolol | 180 | $1,829 | $10 |
| Amlodipine Besylate | 175 | $1,583 | $9 |
| Doxazosin Mesylate | 25 | $1,503 | $60 |
| Carvedilol | 110 | $1,488 | $14 |
| Simvastatin | 115 | $1,380 | $12 |
| Enalapril Maleate | 32 | $1,325 | $41 |
| Valsartan | 30 | $1,290 | $43 |
| Amiodarone | 53 | $1,243 | $23 |
| Fenofibrate | 14 | $1,215 | $87 |
| Isosorbide Mononitrate Er | 43 | $1,204 | $28 |
| Pravastatin | 35 | $1,201 | $34 |
| Toprol Xl | 12 | $1,176 | $98 |
| Clopidogrel | 54 | $1,056 | $20 |
| Verapamil Er | 26 | $1,053 | $41 |
| Losartan-Hydrochlorothiazide | 50 | $965 | $19 |
| Lisinopril | 80 | $825 | $10 |
| Diltiazem 24hr Er | 14 | $727 | $52 |
| Furosemide | 113 | $716 | $6 |
| Spironolactone | 31 | $714 | $23 |
| Hydrochlorothiazide | 98 | $688 | $7 |
| Bumetanide | 13 | $641 | $49 |
| Dilt-Xr | 15 | $520 | $35 |
| Triamterene-Hydrochlorothiazid | 41 | $506 | $12 |
| Hydralazine | 31 | $501 | $16 |
| Pantoprazole | 16 | $499 | $31 |
| Atenolol | 48 | $466 | $10 |
| Ramipril | 17 | $455 | $27 |
| Clonidine | 43 | $454 | $11 |
| Klor-Con Sprinkle | 12 | $413 | $34 |
| Quinapril | 19 | $400 | $21 |
| Fludrocortisone Acetate | 12 | $395 | $33 |
| Valsartan-Hydrochlorothiazide | 18 | $366 | $20 |
| Nitroglycerin | 21 | $294 | $14 |
| Benazepril | 17 | $270 | $16 |
| Diltiazem | 12 | $255 | $21 |
| Amoxicillin | 11 | $20 | $2 |
2017: 55 drugs
| Eliquis | 169 | $114,573 | $678 |
| Xarelto | 65 | $44,579 | $686 |
| Zetia | 54 | $38,724 | $717 |
| Effient | 27 | $20,339 | $753 |
| Crestor | 27 | $15,196 | $563 |
| Ranexa | 24 | $12,879 | $537 |
| Metoprolol | 307 | $11,387 | $37 |
| Pradaxa | 13 | $8,976 | $690 |
| Rosuvastatin | 113 | $8,215 | $73 |
| Atorvastatin | 340 | $7,751 | $23 |
| Ezetimibe | 30 | $6,916 | $231 |
| Flecainide Acetate | 76 | $6,164 | $81 |
| Warfarin | 192 | $5,729 | $30 |
| Potassium Chloride | 136 | $5,682 | $42 |
| Diltiazem 24hr Er | 108 | $4,859 | $45 |
| Losartan | 315 | $3,803 | $12 |
| Niacin Er | 19 | $3,666 | $193 |
| Cartia Xt | 94 | $3,389 | $36 |
| Digox | 34 | $3,222 | $95 |
| Metolazone | 45 | $3,021 | $67 |
| Sotalol | 115 | $2,854 | $25 |
| Benicar | 12 | $2,833 | $236 |
| Coumadin | 14 | $2,267 | $162 |
| Digoxin | 27 | $2,157 | $80 |
| Metoprolol | 177 | $1,970 | $11 |
| Pravastatin | 40 | $1,926 | $48 |
| Amlodipine Besylate | 175 | $1,852 | $11 |
| Isosorbide Mononitrate Er | 53 | $1,687 | $32 |
| Fenofibrate | 15 | $1,466 | $98 |
| Carvedilol | 133 | $1,379 | $10 |
| Enalapril Maleate | 29 | $1,370 | $47 |
| Amiodarone | 46 | $1,304 | $28 |
| Propafenone | 17 | $1,269 | $75 |
| Valsartan | 42 | $1,232 | $29 |
| Simvastatin | 114 | $1,151 | $10 |
| Verapamil Er | 34 | $1,135 | $33 |
| Doxazosin Mesylate | 23 | $980 | $43 |
| Hydrochlorothiazide | 104 | $935 | $9 |
| Clopidogrel | 46 | $913 | $20 |
| Lisinopril | 84 | $827 | $10 |
| Valsartan-Hydrochlorothiazide | 27 | $813 | $30 |
| Klor-Con Sprinkle | 18 | $751 | $42 |
| Losartan-Hydrochlorothiazide | 43 | $731 | $17 |
| Furosemide | 102 | $707 | $7 |
| Atenolol | 65 | $639 | $10 |
| Spironolactone | 27 | $627 | $23 |
| Triamterene-Hydrochlorothiazid | 37 | $532 | $14 |
| Quinapril | 15 | $529 | $35 |
| Ramipril | 25 | $484 | $19 |
| Pantoprazole | 20 | $461 | $23 |
| Nitroglycerin | 24 | $454 | $19 |
| Fludrocortisone Acetate | 12 | $454 | $38 |
| Benazepril | 31 | $351 | $11 |
| Clonidine | 27 | $324 | $12 |
| Jantoven | 12 | $157 | $13 |
2016: 59 drugs
| Eliquis | 116 | $64,661 | $557 |
| Zetia | 94 | $54,303 | $578 |
| Crestor | 88 | $42,813 | $487 |
| Xarelto | 61 | $33,333 | $546 |
| Metoprolol | 295 | $10,344 | $35 |
| Effient | 12 | $9,438 | $787 |
| Atorvastatin | 409 | $8,884 | $22 |
| Vytorin | 20 | $8,714 | $436 |
| Ranexa | 15 | $7,716 | $514 |
| Diltiazem 24hr Er | 140 | $5,975 | $43 |
| Potassium Chloride | 129 | $5,790 | $45 |
| Warfarin | 263 | $5,701 | $22 |
| Valsartan | 46 | $3,751 | $82 |
| Flecainide Acetate | 66 | $3,721 | $56 |
| Losartan | 312 | $3,368 | $11 |
| Rosuvastatin | 35 | $2,950 | $84 |
| Cartia Xt | 64 | $2,877 | $45 |
| Fenofibrate | 15 | $2,553 | $170 |
| Benicar Hct | 12 | $2,463 | $205 |
| Digoxin | 29 | $2,446 | $84 |
| Digox | 45 | $2,169 | $48 |
| Sotalol | 132 | $2,076 | $16 |
| Amlodipine Besylate | 203 | $2,010 | $10 |
| Metoprolol | 225 | $1,996 | $9 |
| Pravastatin | 46 | $1,853 | $40 |
| Simvastatin | 169 | $1,841 | $11 |
| Metolazone | 26 | $1,832 | $70 |
| Ramipril | 36 | $1,783 | $50 |
| Clopidogrel | 86 | $1,627 | $19 |
| Isosorbide Mononitrate Er | 71 | $1,519 | $21 |
| Carvedilol | 158 | $1,508 | $10 |
| Enalapril Maleate | 41 | $1,499 | $37 |
| Diltiazem 24hr Cd | 29 | $1,413 | $49 |
| Valsartan-Hydrochlorothiazide | 39 | $1,256 | $32 |
| Nitrostat | 32 | $961 | $30 |
| Amiodarone | 52 | $909 | $17 |
| Atenolol | 79 | $874 | $11 |
| Hydrochlorothiazide | 110 | $862 | $8 |
| Lisinopril | 91 | $829 | $9 |
| Losartan-Hydrochlorothiazide | 38 | $798 | $21 |
| Furosemide | 113 | $701 | $6 |
| Propafenone | 20 | $670 | $34 |
| Spironolactone | 26 | $591 | $23 |
| Doxazosin Mesylate | 15 | $589 | $39 |
| Quinapril | 21 | $583 | $28 |
| Jantoven | 18 | $570 | $32 |
| Triamterene-Hydrochlorothiazid | 46 | $512 | $11 |
| Bumetanide | 11 | $500 | $45 |
| Verapamil Er | 26 | $484 | $19 |
| Benazepril | 44 | $437 | $10 |
| Clonidine | 32 | $410 | $13 |
| Diltiazem | 17 | $388 | $23 |
| Diltiazem Er | 13 | $371 | $29 |
| Irbesartan | 11 | $299 | $27 |
| Pantoprazole | 26 | $290 | $11 |
| Sotalol Af | 12 | $260 | $22 |
| Fludrocortisone Acetate | 16 | $219 | $14 |
| Lisinopril-Hydrochlorothiazide | 11 | $206 | $19 |
| Lovastatin | 13 | $199 | $15 |
2015: 64 drugs
| Zetia | 107 | $50,968 | $476 |
| Crestor | 81 | $37,150 | $459 |
| Xarelto | 83 | $34,002 | $410 |
| Eliquis | 60 | $25,834 | $431 |
| Metoprolol | 299 | $10,593 | $35 |
| Atorvastatin | 375 | $7,703 | $21 |
| Vytorin | 24 | $7,700 | $321 |
| Ranexa | 13 | $6,656 | $512 |
| Valsartan | 47 | $5,741 | $122 |
| Warfarin | 233 | $5,730 | $25 |
| Benicar | 15 | $5,570 | $371 |
| Potassium Chloride | 118 | $5,025 | $43 |
| Diovan | 19 | $4,383 | $231 |
| Benicar Hct | 15 | $3,758 | $251 |
| Fenofibrate | 20 | $3,552 | $178 |
| Losartan | 271 | $3,220 | $12 |
| Fenofibrate | 14 | $3,024 | $216 |
| Diltiazem 24hr Er | 72 | $2,943 | $41 |
| Enoxaparin | 11 | $2,929 | $266 |
| Digox | 52 | $2,682 | $52 |
| Flecainide Acetate | 47 | $2,421 | $52 |
| Pravastatin | 67 | $2,349 | $35 |
| Digoxin | 36 | $2,293 | $64 |
| Clopidogrel | 95 | $2,141 | $23 |
| Metolazone | 33 | $2,096 | $64 |
| Ramipril | 42 | $1,979 | $47 |
| Amlodipine Besylate | 236 | $1,783 | $8 |
| Cartia Xt | 49 | $1,775 | $36 |
| Valsartan-Hydrochlorothiazide | 32 | $1,647 | $51 |
| Metoprolol | 228 | $1,617 | $7 |
| Simvastatin | 172 | $1,570 | $9 |
| Enalapril Maleate | 43 | $1,498 | $35 |
| Sotalol | 118 | $1,452 | $12 |
| Diltiazem 24hr Cd | 27 | $1,382 | $51 |
| Amiodarone | 69 | $1,374 | $20 |
| Propafenone | 20 | $1,275 | $64 |
| Carvedilol | 124 | $1,258 | $10 |
| Isosorbide Mononitrate Er | 77 | $1,121 | $15 |
| Diltiazem Er | 19 | $1,068 | $56 |
| Losartan-Hydrochlorothiazide | 61 | $826 | $14 |
| Doxazosin Mesylate | 19 | $782 | $41 |
| Atenolol | 71 | $759 | $11 |
| Hydrochlorothiazide | 86 | $739 | $9 |
| Nitrostat | 40 | $716 | $18 |
| Lisinopril | 102 | $694 | $7 |
| Bumetanide | 22 | $658 | $30 |
| Dilt-Xr | 16 | $544 | $34 |
| Quinapril | 19 | $479 | $25 |
| Verapamil Er | 37 | $458 | $12 |
| Furosemide | 97 | $445 | $5 |
| Irbesartan | 18 | $391 | $22 |
| Pantoprazole | 21 | $389 | $19 |
| Sotalol Af | 19 | $309 | $16 |
| Captopril | 17 | $297 | $17 |
| Lovastatin | 18 | $281 | $16 |
| Benazepril | 33 | $275 | $8 |
| Clonidine | 24 | $249 | $10 |
| Triamterene-Hydrochlorothiazid | 22 | $225 | $10 |
| Fludrocortisone Acetate | 15 | $220 | $15 |
| Hydralazine | 17 | $218 | $13 |
| Spironolactone | 17 | $187 | $11 |
| Lisinopril-Hydrochlorothiazide | 13 | $184 | $14 |
| Diltiazem | 11 | $176 | $16 |
| Verapamil | 12 | $94 | $8 |
2014: 59 drugs
| Zetia | 91 | $32,970 | $362 |
| Crestor | 92 | $31,269 | $340 |
| Xarelto | 59 | $21,318 | $361 |
| Diovan | 64 | $19,236 | $301 |
| Vytorin | 37 | $12,052 | $326 |
| Metoprolol | 202 | $11,022 | $55 |
| Atorvastatin | 337 | $8,162 | $24 |
| Benicar | 43 | $8,078 | $188 |
| Enoxaparin | 15 | $6,308 | $421 |
| Eliquis | 18 | $6,263 | $348 |
| Potassium Chloride | 89 | $5,651 | $63 |
| Fenofibrate | 21 | $4,541 | $216 |
| Warfarin | 209 | $4,389 | $21 |
| Valsartan-Hydrochlorothiazide | 41 | $3,857 | $94 |
| Clopidogrel | 95 | $3,645 | $38 |
| Valsartan | 13 | $3,342 | $257 |
| Fenofibrate | 18 | $3,236 | $180 |
| Digox | 61 | $3,034 | $50 |
| Diltiazem 24hr Er | 85 | $2,992 | $35 |
| Digoxin | 46 | $2,518 | $55 |
| Losartan | 171 | $2,496 | $15 |
| Flecainide Acetate | 38 | $2,236 | $59 |
| Sotalol | 148 | $2,182 | $15 |
| Ramipril | 31 | $2,025 | $65 |
| Benicar Hct | 14 | $2,003 | $143 |
| Amiodarone | 56 | $1,955 | $35 |
| Simvastatin | 147 | $1,895 | $13 |
| Metoprolol | 198 | $1,894 | $10 |
| Amlodipine Besylate | 216 | $1,858 | $9 |
| Metolazone | 39 | $1,855 | $48 |
| Isosorbide Mononitrate Er | 81 | $1,681 | $21 |
| Cartia Xt | 36 | $1,659 | $46 |
| Diltiazem Er | 27 | $1,242 | $46 |
| Carvedilol | 97 | $1,153 | $12 |
| Irbesartan | 13 | $1,035 | $80 |
| Losartan-Hydrochlorothiazide | 61 | $1,004 | $16 |
| Enalapril Maleate | 45 | $947 | $21 |
| Propafenone | 12 | $930 | $78 |
| Doxazosin Mesylate | 24 | $845 | $35 |
| Pravastatin | 48 | $841 | $18 |
| Diltiazem 24hr Cd | 22 | $804 | $37 |
| Dilt-Xr | 16 | $633 | $40 |
| Hydrochlorothiazide | 75 | $613 | $8 |
| Atenolol | 76 | $569 | $7 |
| Furosemide | 112 | $561 | $5 |
| Benazepril | 41 | $536 | $13 |
| Verapamil Sr | 13 | $532 | $41 |
| Lisinopril | 71 | $527 | $7 |
| Spironolactone | 27 | $449 | $17 |
| Bumetanide | 36 | $448 | $12 |
| Quinapril | 14 | $414 | $30 |
| Verapamil Er | 33 | $413 | $13 |
| Triamterene-Hydrochlorothiazid | 37 | $379 | $10 |
| Nitrostat | 26 | $373 | $14 |
| Clonidine | 29 | $308 | $11 |
| Lovastatin | 14 | $293 | $21 |
| Sotalol Af | 16 | $272 | $17 |
| Pantoprazole | 11 | $163 | $15 |
| Captopril | 13 | $135 | $10 |
2013: 56 drugs
| Zetia | 64 | $21,765 | $340 |
| Diovan | 69 | $19,932 | $289 |
| Crestor | 51 | $15,866 | $311 |
| Vytorin | 33 | $9,048 | $274 |
| Metoprolol | 131 | $7,912 | $60 |
| Atorvastatin | 209 | $7,845 | $38 |
| Benicar | 34 | $6,081 | $179 |
| Xarelto | 17 | $5,569 | $328 |
| Propafenone | 19 | $5,391 | $284 |
| Niaspan | 12 | $5,042 | $420 |
| Clopidogrel | 77 | $4,706 | $61 |
| Potassium Chloride | 76 | $4,658 | $61 |
| Lipitor | 17 | $4,382 | $258 |
| Valsartan-Hydrochlorothiazide | 32 | $4,029 | $126 |
| Warfarin | 177 | $3,696 | $21 |
| Metolazone | 80 | $3,595 | $45 |
| Diltiazem 24hr Er | 87 | $3,411 | $39 |
| Coreg Cr | 15 | $3,048 | $203 |
| Losartan | 128 | $3,014 | $24 |
| Fenofibrate | 14 | $2,663 | $190 |
| Simvastatin | 161 | $2,205 | $14 |
| Flecainide Acetate | 46 | $2,023 | $44 |
| Metoprolol | 189 | $1,764 | $9 |
| Sotalol | 85 | $1,745 | $21 |
| Cartia Xt | 36 | $1,642 | $46 |
| Losartan-Hydrochlorothiazide | 73 | $1,621 | $22 |
| Amlodipine Besylate | 163 | $1,479 | $9 |
| Diltiazem Er | 22 | $1,229 | $56 |
| Amiodarone | 42 | $1,109 | $26 |
| Diltiazem 24hr Cd | 19 | $1,045 | $55 |
| Irbesartan | 13 | $992 | $76 |
| Digox | 68 | $960 | $14 |
| Isosorbide Mononitrate Er | 37 | $705 | $19 |
| Spironolactone | 28 | $694 | $25 |
| Carvedilol | 36 | $602 | $17 |
| Verapamil Er | 30 | $580 | $19 |
| Ramipril | 14 | $546 | $39 |
| Lisinopril | 66 | $517 | $8 |
| Nitrostat | 35 | $489 | $14 |
| Triamterene-Hctz | 36 | $468 | $13 |
| Bumetanide | 44 | $452 | $10 |
| Pravastatin | 35 | $452 | $13 |
| Hydrochlorothiazide | 52 | $433 | $8 |
| Atenolol | 55 | $430 | $8 |
| Doxazosin Mesylate | 19 | $390 | $21 |
| Enalapril Maleate | 25 | $384 | $15 |
| Digoxin | 22 | $366 | $17 |
| Benazepril | 32 | $358 | $11 |
| Pantoprazole | 16 | $356 | $22 |
| Lovastatin | 15 | $342 | $23 |
| Furosemide | 51 | $278 | $5 |
| Sotalol Af | 16 | $226 | $14 |
| Dilt-Xr | 12 | $221 | $18 |
| Lisinopril-Hydrochlorothiazide | 12 | $198 | $16 |
| Fosinopril | 11 | $125 | $11 |
| Captopril | 11 | $74 | $7 |
Money from drug and device companies
$52 in 2024
| 2024 | 2 | 2 | None | $52 |
| 2023 | 1 | 1 | None | $147 |
| 2022 | 1 | 1 | None | $20 |
| 2021 | 3 | 4 | None | $134 |
| 2020 | 3 | 3 | None | $49 |
| 2019 | 2 | 23 | None | $209 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $29 | 1 payment
|
| Boston Scientific | Watchman Flx | $23 | 1 payment
|
See all 2 published payments
| Janssen Pharmaceuticals | Meals · 2024-05-15 | Xarelto | $29 |
| Boston Scientific | Meals · 2024-02-24 | Watchman Flx | $23 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $147
| Acist Medical Systems | Hd-Ivus | $147 | 1 payment
|
2022: $20
| Abbott Laboratories | Mitraclip | $20 | 1 payment
|
2021: $134
| AstraZeneca Pharmaceuticals LP | Brilinta | $75 | 1 payment
|
| Abbott Laboratories | Mitraclip System | $38 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $21 | 1 payment
|
2020: $49
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $22 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $14 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $13 | 1 payment
|
2019: $209
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $142 | 20 payments
|
| Sanofi-Aventis U.S. | Praluent | $67 | 3 payments
|
Professional record
- NPI
- 1649258005
- Licence
- CA G57335California G57335: Current · expires 2028-02-29
- Trained
- Stanford University School of Medicine, 1982
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-01-05
- NPI last updated
- 2016-03-21
This is when the NPI record was last certified, not a medical board exam.